VIP/PACAP oppositely effects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells

Journal of Leukocyte Biology

Volumn 75, Issue 6, 2004, Pages 1122-1130

  Delgado, Mario ^a,b   Reduta, Allan ^a   Sharma, Vikas ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Bone marrow derived dendritic cells; Neuropeptides; T cell proliferation; Th1 Th2 effectors

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TH2 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; DENDRITIC CELLS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TH1 CELLS; TH2 CELLS; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA;

EID: 2642550835     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203626     Document Type: Article

References (27)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
2. Moll, H. (2003) Dendritic cells and host resistance to infection. Cell. Microbiol. 5, 493-500.
3. Moser, M. (2003) Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity 19, 5-8.
4. Itano, A. A., Jenkins, M. K. (2003) Antigen presentation to naïve CD4 T cells in the lymph node. Nat. Immunol. 4, 733-739.
5. Banchereau, J., Paczesnt, S., Blanco, P., Bennett, L., Pascual, V., Fay, J., Palucka, A. K. (2003) Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann. N. Y. Acad. Sci. 987, 180-187.
6. Fogdor, C. G. (2003) Molecular characterization of dendritic cells operating at the interface of innate or acquired immunity. Pathol. Biol. 51, 61-63.
7. Luger, T. A. (2002) Neuromediators - a crucial component of the skin immune system. J. Dermatol. Sci. 30, 87-93.
8. Lambrecht, B. N. (2001) Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res. 2, 133-138.
9. Torii, H., Tamaki, K., Granstein, R. D. (1998) The effect of neuropeptides/hormones on Langerhans cells. J. Dermatol. Sci. 20, 21-28.
10. Ardavin, C. (2003) Origin, precursors and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 3, 582-590.
11. Shortman, K., Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
12. Ganea, D., Rodriguez, R., Delgado, M. (2003) Vasoactive intestinal peptide and pituitary, adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Cell. Mol. Biol. (Noisy-le-grand) 49, 127-142.
13. Ganea, D., Delgado, M. (2003) The neuropeptides VIP/PACAP and T cells: inhibitors or activators? Curr. Pharm. Des. 9, 997-1004.
14. Delgado, M., Abad, C., Martinez, C., Guillerma Juarranz, M., Leceta, J., Ganea, D., Gomariz, R. P. (2003) PACAP in immunity and inflammation. Ann. N. Y. Acad. Sci. 992, 141-157.
15. Delneste, Y., Herbault, N., Galea, B., Magistrelli, G., Bazin, I., Bonnefoy, J-Y., Jeannin, P. (1999) Vasoactive intestinal peptide synergizes with TNF-α in inducing human dendritic cell maturation. J. Immunol. 163, 3071-3075.
16. Dunzendorfer, S., Kaser, A., Meierhofer, C., Tilg, H., Wiedermann, C. J. (2001) Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J. Immunol. 166, 2167-2172.
17. Vassiliou, E., Jing, H., Ganea, D. (2003) Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell. Immunol. 223, 120-132.
18. Harmar, A., Arimura, A., Gozes, I., Journot, L., Laburthe, M., Pisegna, J. R., Rawlings, S. R., Robberecht, P., Said, S. I., Sreedharan, S. P., Wank, S. A., Waschek, J. A. (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50, 265-270.
19. Gomariz, R. P., Martinez, C., Abad, C., Leceta, J., Delgado, M. (2001) Immunology of VIP: a review and therapeutical perspectives. Curr. Pharm. Des. 7, 89-111.
20. Torii, H., Yan, Z., Hosoi, J., Granstein, R. D. (1997) Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J. Invest. Dermatol. 109, 586-591.
21. Delgado, M., Sun, W., Leceta, J., Ganea, D. (1999) VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J. Immunol. 163, 4213-4223.
22. Delgado, M., Leceta, J., Gomariz, R. P., Ganea, D. (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J. Immunol. 163, 3629-3635.
23. Delgado, M., Leceta, J., Ganea, D. (2002) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells. FASEB J. 16, 1844-1846.
24. Goetzl, E. J., Voice, J. K., Shen, S., Dorsam, G., Kong, Y., West, K. M., Morrison, C. F., Harmar, A. J. (2001) Enhanced delayed-type hypersensitivity and diminished immediate type hypersensitivity in mice lacking the inducible VPAC(2) receptor for VIP. Proc. Natl. Acad. Sci. USA 98, 13854-13859.
25. Voice, J. K., Dorsam, G., Lee, H., Kong, Y., Goetzl, E. J. (2001) Allergic diathesis in transgenic mice with constitutive T cell expression of inducible VIP receptor. FASEB J. 15, 2489-2496.
26. Voice, J. K., Grinninger, A., Kong, Y., Bangale, Y., Paul, S., Goetzl, E. J. (2003) Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T-cell targeted type II VIP receptor transgenic mice. J. Immunol. 170, 308-314.
27. Morita, R., Ukyo, N., Furuya, M., Uchiyama, T., Hori, T. (2003) Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A. J. Immunol. 170, 5869-5875.